A
AprilBio Co Ltd
KOSDAQ:397030
AprilBio Co Ltd
KOSDAQ:397030
Price:
15 530 KRW
Market Closed
Updated:
May 19, 2024
Section:
Relative Value
The Relative Value of one AprilBio Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 15 530 KRW, AprilBio Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AprilBio Co Ltd Relative Value
HIDDEN
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
AprilBio Co Ltd Competitors
AprilBio Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
A
|
AprilBio Co Ltd
KOSDAQ:397030
|
332.7B KRW | 1 663.4 | -35.9 | -23.4 | -22.2 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
293.9B USD | 5.4 | 49.4 | 13.8 | 21.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
167.6B USD | 5.7 | 44.5 | 18.7 | 30.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115B USD | 11.3 | 28.6 | 24 | 25.1 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
108.2B USD | 8.3 | 28.1 | 22.7 | 25.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
135.3B AUD | 6.4 | 36.6 | 22.1 | 27.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
84.4B USD | 3.1 | 174.3 | 8.8 | 11.6 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
50.9B USD | 9.9 | -8.5 | -9.4 | -8.4 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
33.6B USD | 3.5 | 28.8 | 14.6 | 18.3 | |
| KR |
|
Celltrion Inc
KRX:068270
|
39.7T KRW | 18.2 | 74.1 | 45.3 | 62.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
